|
C15ORF41 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.550300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.303200E-03 |
| Normal-vs-Stage2 |
6.282600E-03 |
| Normal-vs-Stage3 |
2.544800E-03 |
| Normal-vs-Stage4 |
3.049600E-04 |
| Stage1-vs-Stage2 |
3.428400E-01 |
| Stage1-vs-Stage3 |
4.394600E-01 |
| Stage1-vs-Stage4 |
2.463800E-01 |
| Stage2-vs-Stage3 |
7.519200E-01 |
| Stage2-vs-Stage4 |
9.907000E-01 |
| Stage3-vs-Stage4 |
6.895400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.762300E-04 |
| Normal-vs-AfricanAmerican |
7.984900E-03 |
| Normal-vs-Asian |
7.044100E-02 |
| Caucasian-vs-AfricanAmerican |
5.311600E-01 |
| Caucasian-vs-Asian |
4.371000E-01 |
| AfricanAmerican-vs-Asian |
3.024200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.831800E-04 |
| Normal-vs-Female |
2.138100E-03 |
| Male-vs-Female |
8.553600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.936800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.603540E-03 |
| Normal-vs-Age(61-80Yrs) |
5.232100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.476270E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.730200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.642200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.120400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.983400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.822400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.902400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.612000E-01 |
| Normal-vs-Grade 2 |
9.176500E-03 |
| Normal-vs-Grade 3 |
4.230300E-04 |
| Normal-vs-Grade 4 |
3.584600E-04 |
| Grade 1-vs-Grade 2 |
2.354400E-01 |
| Grade 1-vs-Grade 3 |
6.150200E-02 |
| Grade 1-vs-Grade 4 |
1.205790E-01 |
| Grade 2-vs-Grade 3 |
1.725200E-01 |
| Grade 2-vs-Grade 4 |
1.644990E-01 |
| Grade 3-vs-Grade 4 |
7.160200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.864000E-03 |
| Normal-vs-ccB subtype |
3.535100E-03 |
| ccA subtype-vs-ccB subtype |
4.925600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.793000E-04 |
| Normal-vs-N1 |
7.688100E-02 |
| N0-vs-N1 |
9.087800E-01 |
|
|
